NEUROD4
geneOn this page
Also known as Atoh3ATH-3MATH-3bHLHa4
Summary
NEUROD4 (neuronal differentiation 4, HGNC:13802) is a protein-coding gene on chromosome 12q13.2, encoding Neurogenic differentiation factor 4 (Q9HD90). Probably acts as a transcriptional activator.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and E-box binding activity. Predicted to be involved in neuron differentiation; positive regulation of cell differentiation; and positive regulation of transcription by RNA polymerase II. Predicted to act upstream of or within Notch signaling pathway; cell fate commitment; and neurogenesis. Predicted to be located in chromatin. Predicted to be active in nucleus.
Source: NCBI Gene 58158 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_021191
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13802 |
| Approved symbol | NEUROD4 |
| Name | neuronal differentiation 4 |
| Location | 12q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Atoh3, ATH-3, MATH-3, bHLHa4 |
| Ensembl gene | ENSG00000123307 |
| Ensembl biotype | protein_coding |
| OMIM | 611635 |
| Entrez | 58158 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000242994
RefSeq mRNA: 1 — MANE Select: NM_021191
NM_021191
CCDS: CCDS8886
Canonical transcript exons
ENST00000242994 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000838468 | 55026431 | 55030017 |
| ENSE00001117345 | 55019974 | 55020313 |
Expression profiles
Bgee: expression breadth broad, 29 present calls, max score 92.37.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 3.8958 / max 2532.3005, expressed in 120 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 125949 | 3.2053 | 110 |
| 125947 | 0.3464 | 50 |
| 125948 | 0.3441 | 43 |
Top tissues by expression
277 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ganglionic eminence | UBERON:0004023 | 92.37 | gold quality |
| ventricular zone | UBERON:0003053 | 79.33 | gold quality |
| embryo | UBERON:0000922 | 75.62 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.58 | silver quality |
| pituitary gland | UBERON:0000007 | 73.16 | gold quality |
| adenohypophysis | UBERON:0002196 | 72.62 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 61.66 | gold quality |
| tibialis anterior | UBERON:0001385 | 60.51 | silver quality |
| pancreatic ductal cell | CL:0002079 | 60.29 | silver quality |
| ileal mucosa | UBERON:0000331 | 60.16 | silver quality |
| cortical plate | UBERON:0005343 | 57.65 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 56.06 | gold quality |
| endothelial cell | CL:0000115 | 52.44 | gold quality |
| deltoid | UBERON:0001476 | 51.94 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 51.64 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 51.25 | gold quality |
| parotid gland | UBERON:0001831 | 50.00 | gold quality |
| quadriceps femoris | UBERON:0001377 | 49.98 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.52 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 49.22 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| myocardium | UBERON:0002349 | 49.19 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| cerebellar vermis | UBERON:0004720 | 48.93 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.47 | gold quality |
| upper leg skin | UBERON:0004262 | 48.27 | silver quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-11121 | yes | 881.05 |
| E-MTAB-7316 | yes | 45.66 |
| E-GEOD-137537 | yes | 18.92 |
| E-ANND-3 | yes | 2.62 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
4 targets.
| Target | Regulation |
|---|---|
| FGFR1 | |
| KRT9 | |
| ME3 | |
| VIPR1 |
Upstream regulators (CollecTRI, top): CHD8, FOXN4, ISL1, NEUROG2, NEUROG3, NFIA, NFIB, NFIX, RELA
miRNA regulators (miRDB)
132 targeting NEUROD4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-1193 | 100.00 | 65.93 | 529 |
| HSA-MIR-4713-3P | 100.00 | 65.92 | 505 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | neurod4 | ENSDARG00000003469 |
| mus_musculus | Neurod4 | ENSMUSG00000048015 |
| rattus_norvegicus | Neurod4 | ENSRNOG00000008449 |
| drosophila_melanogaster | amos | FBGN0003270 |
| drosophila_melanogaster | ato | FBGN0010433 |
| drosophila_melanogaster | tap | FBGN0015550 |
| caenorhabditis_elegans | WBGENE00003018 | |
| caenorhabditis_elegans | WBGENE00003595 |
Paralogs (15): NEUROG3 (ENSG00000122859), BHLHE23 (ENSG00000125533), NEUROD1 (ENSG00000162992), NEUROD6 (ENSG00000164600), ATOH8 (ENSG00000168874), NEUROD2 (ENSG00000171532), ATOH1 (ENSG00000172238), OLIG3 (ENSG00000177468), NEUROG2 (ENSG00000178403), ATOH7 (ENSG00000179774), BHLHA15 (ENSG00000180535), BHLHE22 (ENSG00000180828), NEUROG1 (ENSG00000181965), OLIG1 (ENSG00000184221), OLIG2 (ENSG00000205927)
Protein
Protein identifiers
Neurogenic differentiation factor 4 — Q9HD90 (reviewed: Q9HD90)
Alternative names: Class A basic helix-loop-helix protein 4, Protein atonal homolog 3
All UniProt accessions (1): Q9HD90
UniProt curated annotations — full annotation on UniProt →
Function. Probably acts as a transcriptional activator. Mediates neuronal differentiation. Required for the regulation of amacrine cell fate specification in the retina.
Subunit / interactions. Efficient DNA binding requires dimerization with another bHLH protein.
Subcellular location. Nucleus.
Post-translational modifications. Serine or threonine phosphorylation within the basic region may regulate neurogenic activity.
RefSeq proteins (1): NP_067014* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011598 | bHLH_dom | Domain |
| IPR016637 | TF_bHLH_NeuroD | Family |
| IPR022575 | NeuroD_DUF | Domain |
| IPR036638 | HLH_DNA-bd_sf | Homologous_superfamily |
| IPR050359 | bHLH_transcription_factors | Family |
Pfam: PF00010, PF12533
UniProt features (8 total): region of interest 2, compositionally biased region 2, chain 1, domain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HD90-F1 | 63.06 | 0.26 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 139 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, GOBP_NEUROGENESIS, GOBP_NEURAL_RETINA_DEVELOPMENT, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION, MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN, MARTINEZ_RB1_TARGETS_UP, TCF4_Q5, GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION, GGARNTKYCCA_UNKNOWN, GOCC_CENTROSOME, GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION, GOBP_NEURON_MIGRATION, HFH1_01, AACTTT_UNKNOWN
GO Biological Process (15): Notch signaling pathway (GO:0007219), neuroblast proliferation (GO:0007405), amacrine cell differentiation (GO:0035881), camera-type eye development (GO:0043010), cell fate commitment (GO:0045165), positive regulation of cell differentiation (GO:0045597), positive regulation of transcription by RNA polymerase II (GO:0045944), oligodendrocyte differentiation (GO:0048709), axon development (GO:0061564), motor neuron migration (GO:0097475), regulation of DNA-templated transcription (GO:0006355), nervous system development (GO:0007399), cell differentiation (GO:0030154), neuron development (GO:0048666), retina development in camera-type eye (GO:0060041)
GO Molecular Function (6): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), protein dimerization activity (GO:0046983), E-box binding (GO:0070888), DNA binding (GO:0003677), protein binding (GO:0005515), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell differentiation | 2 |
| cellular developmental process | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| cell surface receptor signaling pathway | 1 |
| generation of neurons | 1 |
| neural precursor cell proliferation | 1 |
| neural retina development | 1 |
| central nervous system neuron differentiation | 1 |
| eye development | 1 |
| regulation of cell differentiation | 1 |
| positive regulation of cellular process | 1 |
| positive regulation of developmental process | 1 |
| transcription by RNA polymerase II | 1 |
| positive regulation of DNA-templated transcription | 1 |
| central nervous system development | 1 |
| glial cell differentiation | 1 |
| neuron projection development | 1 |
| neuron migration | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| system development | 1 |
| neuron differentiation | 1 |
| cell development | 1 |
| camera-type eye development | 1 |
| anatomical structure development | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| protein binding | 1 |
| RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
656 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NEUROD4 | FOXN4 | Q96NZ1 | 936 |
| NEUROD4 | ASCL1 | P50553 | 755 |
| NEUROD4 | ISL1 | P20663 | 754 |
| NEUROD4 | LHX3 | Q9UBR4 | 679 |
| NEUROD4 | HOXB2 | P10913 | 652 |
| NEUROD4 | VSX2 | P58304 | 629 |
| NEUROD4 | PROX1 | Q92786 | 629 |
| NEUROD4 | HOXA2 | O43364 | 600 |
| NEUROD4 | PAX6 | P26367 | 593 |
| NEUROD4 | POU4F2 | Q12837 | 558 |
| NEUROD4 | PHOX2B | Q99453 | 549 |
| NEUROD4 | CRX | O43186 | 523 |
| NEUROD4 | BARHL2 | Q9NY43 | 508 |
| NEUROD4 | HES5 | Q5TA89 | 477 |
| NEUROD4 | POU4F1 | Q01851 | 457 |
IntAct
15 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PIN1 | NEUROD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCF4 | NEUROD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAGEB4 | NEUROD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GABRB1 | NEUROD4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| LRRN2 | NEUROD4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NEUROD4 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| NEUROD4 | TCF4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MAGEB4 | NEUROD4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (15): NEUROD4 (Two-hybrid), PIN1 (Two-hybrid), TCF4 (Two-hybrid), NEUROD4 (Positive Genetic), SRP19 (Affinity Capture-MS), ADPRHL2 (Affinity Capture-MS), TCF12 (Affinity Capture-MS), POTEF (Affinity Capture-MS), TCF3 (Affinity Capture-MS), NEUROD4 (Affinity Capture-MS), NEUROD4 (Affinity Capture-MS), NEUROD4 (Affinity Capture-MS), NEUROD4 (Affinity Capture-MS), NEUROD4 (Two-hybrid), NEUROD4 (Two-hybrid)
ESM2 similar proteins: A3KNX5, A5YC49, A6NJ46, A6NNA5, F1Q4R9, O09105, O35137, P12979, P15173, P15375, P17920, P19335, P20428, P23409, P28322, P31276, P34060, P34061, P43268, P43688, P48985, P49812, P70368, P70436, P70661, Q01795, Q08856, Q1KKY2, Q32NH9, Q3MHT3, Q3UHX8, Q3YFL6, Q4G112, Q5ND04, Q5RJB0, Q5TIS6, Q62798, Q66HH3, Q66IG8, Q6VNZ9
Diamond homologs: A6NI15, O08574, O09105, O42202, P41894, P46581, P48986, P79765, P79766, P79920, P97309, Q08DI0, Q0VG99, Q13562, Q28C89, Q4R5G6, Q60430, Q60867, Q64289, Q90ZL1, Q91616, Q96NK8, Q9BRJ9, Q9DEQ9, Q9HD90, Q9JK54, Q9W690, Q9W6C7, Q9Y4Z2, A8E5T6, B6VQA1, O09029, O13125, O13126, O16867, O35437, O42606, O43680, O45489, O57598
SIGNOR signaling
5 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| NEUROG3 | “down-regulates quantity by repression” | NEUROD4 | “transcriptional regulation” |
| NFIA | “up-regulates quantity” | NEUROD4 | “transcriptional regulation” |
| NFIB | “up-regulates quantity” | NEUROD4 | “transcriptional regulation” |
| NFIX | “up-regulates quantity” | NEUROD4 | “transcriptional regulation” |
| CHD8 | “down-regulates quantity” | NEUROD4 | “transcriptional regulation” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
185 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:55026429:A:AG | acceptor_gain | 0.9900 |
| 12:55026430:G:GG | acceptor_gain | 0.9900 |
| 12:55026430:GA:G | acceptor_gain | 0.9900 |
| 12:55020309:CCGAG:C | donor_loss | 0.9700 |
| 12:55020310:CGAG:C | donor_loss | 0.9700 |
| 12:55020311:GAGGT:G | donor_loss | 0.9700 |
| 12:55020312:AGGT:A | donor_loss | 0.9700 |
| 12:55020314:G:GA | donor_loss | 0.9700 |
| 12:55020315:T:A | donor_loss | 0.9700 |
| 12:55026425:TTCCA:T | acceptor_loss | 0.9700 |
| 12:55026427:CCAGA:C | acceptor_loss | 0.9700 |
| 12:55026429:A:G | acceptor_loss | 0.9700 |
| 12:55026430:G:A | acceptor_loss | 0.9700 |
| 12:55026430:GAGT:G | acceptor_gain | 0.9700 |
| 12:55020311:GAG:G | donor_gain | 0.9400 |
| 12:55020297:A:T | donor_gain | 0.9300 |
| 12:55026430:GAGTC:G | acceptor_gain | 0.9100 |
| 12:55020314:G:GG | donor_gain | 0.9000 |
| 12:55020123:G:GT | donor_gain | 0.8900 |
| 12:55020296:G:GT | donor_gain | 0.8600 |
| 12:55026430:G:C | acceptor_gain | 0.8600 |
| 12:55020316:GA:G | donor_loss | 0.8500 |
| 12:55026428:CAG:C | acceptor_gain | 0.8300 |
| 12:55026429:AGA:A | acceptor_gain | 0.8300 |
| 12:55026427:CCAG:C | acceptor_gain | 0.8200 |
| 12:55020239:G:GT | donor_gain | 0.7500 |
| 12:55026417:T:G | acceptor_loss | 0.7200 |
| 12:55020124:A:T | donor_gain | 0.6100 |
| 12:55020176:GAG:G | donor_gain | 0.6000 |
| 12:55026426:TCCAG:T | acceptor_gain | 0.5900 |
AlphaMissense
2182 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:55026705:G:C | R89T | 1.000 |
| 12:55026706:A:C | R89S | 1.000 |
| 12:55026706:A:T | R89S | 1.000 |
| 12:55026713:G:C | A92P | 1.000 |
| 12:55026714:C:A | A92D | 1.000 |
| 12:55026718:T:A | N93K | 1.000 |
| 12:55026718:T:G | N93K | 1.000 |
| 12:55026719:G:C | A94P | 1.000 |
| 12:55026724:A:C | R95S | 1.000 |
| 12:55026724:A:T | R95S | 1.000 |
| 12:55026725:G:A | E96K | 1.000 |
| 12:55026726:A:C | E96A | 1.000 |
| 12:55026726:A:T | E96V | 1.000 |
| 12:55026727:A:C | E96D | 1.000 |
| 12:55026727:A:T | E96D | 1.000 |
| 12:55026729:G:C | R97P | 1.000 |
| 12:55026734:C:G | R99G | 1.000 |
| 12:55026734:C:T | R99W | 1.000 |
| 12:55026735:G:C | R99P | 1.000 |
| 12:55026738:T:A | M100K | 1.000 |
| 12:55026738:T:C | M100T | 1.000 |
| 12:55026738:T:G | M100R | 1.000 |
| 12:55026740:C:G | H101D | 1.000 |
| 12:55026741:A:C | H101P | 1.000 |
| 12:55026747:T:A | L103Q | 1.000 |
| 12:55026747:T:C | L103P | 1.000 |
| 12:55026749:A:G | N104D | 1.000 |
| 12:55026750:A:T | N104I | 1.000 |
| 12:55026751:T:A | N104K | 1.000 |
| 12:55026751:T:G | N104K | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000437275 (12:55020271 C>G,T), RS1000468533 (12:55019904 T>C), RS1000575079 (12:55026273 T>C), RS1001231042 (12:55020609 C>T), RS1001585366 (12:55019587 C>T), RS1001602221 (12:55020266 T>C), RS1001786091 (12:55026113 T>C), RS1002091790 (12:55025289 G>C), RS1002215516 (12:55025794 A>G), RS1002543183 (12:55029467 G>A), RS1002895840 (12:55030431 A>G), RS1003234813 (12:55018366 A>G), RS1003265888 (12:55018129 T>A,C), RS1003487178 (12:55024386 A>G,T), RS1003863942 (12:55024655 G>C)
Disease associations
OMIM: gene MIM:611635 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002935_8 | Lead levels | 1.000000e-06 |
| GCST003123_27 | Severe influenza A (H1N1) infection | 1.000000e-10 |
| GCST007995_38 | Asthma (childhood onset) | 1.000000e-10 |
| GCST008181_20 | Spontaneous preterm birth without premature rupture of membranes | 3.000000e-06 |
| GCST010002_217 | Refractive error | 6.000000e-174 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:1001488 | influenza A (H1N1) |
| EFO:0006917 | spontaneous preterm birth |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| clothianidin | decreases expression | 1 |
| bisphenol S | affects cotreatment, decreases methylation | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
| Lead | affects expression | 1 |
| 1-Methyl-4-phenylpyridinium | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A4K6 | SEES3-1V human NEUROD4, clone1 | Embryonic stem cell | Male |
| CVCL_A4K7 | SEES3-1V human NEUROD4, clone2 | Embryonic stem cell | Male |
| CVCL_A4K8 | SEES3-1V human NEUROD4, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): childhood onset asthma